DanGer Shock Trial (Version 1.0)
Research type
Research Study
Full title
Effect of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock
IRAS ID
286689
Contact name
Vasileios Panoulas
Contact email
Sponsor organisation
Odense University
Clinicaltrials.gov Identifier
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
The purpose of our study is to find out whether a small pump called Impella, inserted through an artery in the groin, can improve the chance of survival in patients with shock from a heart attack. The function of the Impella pump is characterized by the fact that it draws blood from the failing heart and pumps it into the circulation. The pump relieves the heart and improves the blood supply to the failing organs. The Impella pump can thus partially take over the function of the heart, since it can pump up to 3.5 l of blood per minute into the body. The Impella pump is already approved for the treatment of shock with reduced pumping power of the heart, but it has not yet been proven whether this pump can increase the chance of survival compared to the usual treatment.
REC name
Wales REC 4
REC reference
21/WA/0031
Date of REC Opinion
4 Feb 2021
REC opinion
Favourable Opinion